Combining Clinical and Angiographic Variables for Estimating Risk of Target Lesion Revascularization after Drug Eluting Stent Placement

Drug-eluting stents (DES) reduce restenosis but require prolonged antiplatelet therapy, when compared with bare metal stents. Ideally, the patient should be involved in this risk:benefit assessment prior to selecting DES, to maximize the benefits and cost-effectiveness of care, and to improve medication adherence. However, accurate estimation of restenosis risk may require angiographic factors identified at cardiac catheterization.

Source: Cardiovascular Revascularization Medicine - December 16, 2016 Category: Cardiology Authors: Joshua M. Stolker, David J. Cohen, Kevin F. Kennedy, Michael J. Pencina, Suzanne V. Arnold, Neal S. Kleiman, John A. Spertus, EVENT Investigators Source Type: research